GSTM1 and GSTT1 Allele Frequencies among Various Indian and non-Indian Ethnic Groups

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 6263-6267

  Senthilkumar, K P ^a,b   Thirumurugan, R ^a,c  

^a Madura College Autonomous   (India)

^b Shree M and N Virani Science College   (India)

^c BHARATHIDASAN UNIVERSITY   (India)

Author keywords

Disease susceptibility; Ethnic variation; GST null genotypes; Homozygosity; Xenobiotics

Indexed keywords

GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ARTICLE; ASIAN; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HOMOZYGOTE; HUMAN; INDIA; MALE; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HOMOZYGOTE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84877025027     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6263     Document Type: Article

References (33)

1. Amer MA, Ghattas MH, Abo-ElMatty DM, Abou-El-Ela SH (2011). Influence of glutathione S-transferase polymorphisms on type-2 diabetes mellitus risk. Genet Mol Res, 10, 3722-30.
2. Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB (2007). Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis, 28, 1455-62.
3. Andres PL, Skerry LM, Munsat TL, Thornell BJ, Szymonifka J, Schoenfeld DA et al. (2012) Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials. Muscle Nerve, 45, 81-5.
4. Buch S, Kotekar A, Kawle D, Bhisey R (2001). Polymorphisms at CYP and GST gene loci. Prevalence in the Indian population. Eur J Clin Pharmacol, 57, 553-5.
5. Deisseroth A, Kaminskas E, Grillo J, et al (2012). U.S. food and drug administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosis. Clin Cancer Res, 18, 3212-7.
6. Ebeshi BU, Bolaji OO, Masimirembwa CM (2011). Glutothione-S-transferase (M1 and T1) polymorphisms in Nigerian populations. J Med Genet Genomics, 3, 56-60.
7. Habdous M, Herbeth B, Haddy N, et al (2004). Smoking, genetic polymorphisms of glutathione S-transferases and biological indices of inflammation and cellular adhesion in the Stainlas study. Excli, 3, 58-67.
8. Hamdy SI, Hiratsuka M, Narahara K, et al (2003). Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol, 55, 560-9.
9. Hirvonen A (1999). Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Hlth Perspect, 107, 37-47.
10. Jiang Z, Liang K, Zhang Q, Tao L (2012). Glutathione S-transferases polymorphisms confer susceptibility to senile cortical cataract in the Han Chinese population. Mol vis, 18, 1247-52.
11. Kappert K, Böhm M, Schmieder R, et al (2012). Impact of gender on cardiovascular outcome in patients at cardiovascular high risk: analysis of the telmisartan randomized assessment study in ace-intolerant subjects with cardiovascular disease (transcend) and the ongoing telmisartan alone and incombination with ramipril global endpoint trial (Ontarget). Circulation, doi: 10.1161/CIRCULATIONAHA.111.086660.
12. Kathuria V (2007). Informal regulation of pollution in a developing country: Evidence from India. Ecol Econ, 63, 403-17.
13. Konwar R, Manchanda PK, Chaudhary P, et al (2010). Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: a report in a North Indian population. Asian Pac J Cancer Prev, 11, 1067-72.
14. Kui H, Robert SS, Robert CM, et al (2006). GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States). Cancer causes and Control, 17, 385-94.
15. Kunak SC, Ada AO, Karacaoglan V, et al (2012). Drug/xenobiotic metabolizing enzyme polymorphisms in a Turkish population. Afr J Pharm Pharacol, 6, 2068-74
16. Kurose K, Sugiyama E, Saito Y (2012). Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinetics, 27, 9-54.
17. Lacko M, Ophuis MB, Peters HM, Manni JJ (2009). Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility. Anticancer Res, 29, 753-61.
18. Lahiri DK, Nurnberger JI (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl Acids Res, 19, 5444.
19. Laing RE, Hess P, Shen Y, Wang J, Hu SX (2011). The role and impact of SNPs in pharmacogenomics and personalized medicine. Curr Drug Metab, 12, 460-86.
20. Lordelo GS, Vilela AL, Akimoto AK, et al (2012). Association between methylene tetrahydrofolate reductase and glutathione S-transferase M1 gene polymorphisms and chronic myeloid leukemia in a Brazilian population. Genet Mol Res, 11, 1013-26.
21. Magno L AV, Talbot J, Talbot T, et al (2009). Glutathione-S-transferase variants in a Brazilian population. Pharmacology, 83, 231-236.
22. Masood N, Kayani MA, Malik FA, et al (2011). Genetic variations in carcinogen metabolizing genes associated with oral cancer in Pakistani population. Asian Pac J Cancer Prev, 12, 491-5.
23. Mishra DK, Kumar A, Srivastava DS, Mittal RD (2004). Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population. Asian Pac J Cancer Prev, 5, 362-5.
24. Naveen AT, Adithan C, Padmaja N, et al (2004). Glutathione S-transferase M1 and T1 null genotype distribution in South Indians. Eur J Clin Pharmacol, 60, 403-6.
25. Nosheen M, Ishrat M, Malik FA, Baig RM, Kayani MA (2010). Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study. Asian Pac J Cancer Prev, 11, 881-5.
26. Oke B, Akbas F, Aydin M, Berkkan H (1998). GSTT1 null genotype frequency in a Turkish population. Arch Toxicol, 72, 454-5.
27. Poste G, Carbone DP, Parkinson DR, et al (2012). Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development. Clin Cancer Res, 18, 1515-23.
28. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 6, 733-43.
29. Reszka E, Wasowicz W, Gromadzinska J (2006). Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility. Brit J Nutr, 96, 609-19.
30. Rossini A, Rapozo CM, Amorim MF, et al (2002). Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res, 1, 233-40.
31. Roy B, Dey B, Chakraborty M, Majumder PP (1998). Frequency of homozygous null mutation at the glutathione-s-transferase M1 locus in some populations of Orissa, India. Anthropol Anz, 56, 43-7.
32. Singh A, Kohli JS (2012). Effect of Pollution on common man in India: a legal perspective. Advances in Life Sci and Technology, 4, 35-41.
33. Vetriselvi V, Vijayalakshmi K, Solomon FD, Venkatachalam P (2006). Genetic variation of GSTM1, GSTT1 and GSTP1 genes in a South Indian population. Asian Pac J Cancer Prev, 7, 325-8.